Literature DB >> 6663043

Long-term follow-up of duodenal ulcer patients.

J D Elashoff, G Van Deventer, T J Reedy, A Ippoliti, I M Samloff, J Kurata, M Billings, M Isenberg.   

Abstract

The CURE peptic ulcer clinic started in April 1974. Patients (mostly veterans) with documented ulcer disease were interviewed regularly and inpatient hospitalizations were reviewed for follow-up periods of up to 6 years. Data from 245 male ulcer patients, 190 with duodenal ulcer alone and 55 with both documented duodenal ulcer (DU) and gastric ulcer (GU), were analyzed to assess the natural history of ulcer disease and factors predicting the severity of its course. Eleven percent of clinic patients had a complication (bleeding requiring a transfusion, perforation, or obstruction) during follow-up. Complication rates were about 2.7% per year for those with no prior complication, and about 5% per year for those with a prior complication. No patient variables or ulcer markers were related to the likelihood of a complication. Patients with both DU and GU were similar to patients with DU alone on many background variables, but the combined ulcer group had a significantly higher frequency of blood group nonsecretors, increased incidence of cigarette smoking, and greater frequency of complications or ulcer hospitalization prior to entry into the study and during follow-up. These factors, together with our failure to find differences in aggressive factors (acid output and PGI), suggests that DU + GU represents a different disease entity marked by additional defects in mucosal defense.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6663043     DOI: 10.1097/00004836-198312000-00008

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.

Authors:  C W Howden
Journal:  BMJ       Date:  1988-11-26

2.  [Selective proximal vagotomy in the treatment of duodenal ulcer. Analysis of clinical results up to the 10th postoperative year].

Authors:  M Raab; H Stützer
Journal:  Langenbecks Arch Chir       Date:  1986

3.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

4.  Relapse of duodenal ulcer.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

5.  Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease.

Authors:  C W Ko; R A Deyo
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

6.  Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with "classical" stump closure (Nissen-Bsteh).

Authors:  Yogesh K Vashist; Emre F Yekebas; Florian Gebauer; Michael Tachezy; Kai Bachmann; Alexandra König; Asad Kutup; Jakob R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2012-08-19       Impact factor: 3.445

7.  Prognosis of chronic duodenal ulcer: a prospective study of the effects of demographic and environmental factors and ulcer healing.

Authors:  R W Nasiry; J H McIntosh; K Byth; D W Piper
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

Review 8.  Complications associated with ulcer recurrence following gastric surgery for ulcer disease.

Authors:  J G Penston; E J Boyd; K G Wormsley
Journal:  Gastroenterol Jpn       Date:  1992-02

9.  Long term management of duodenal ulcer in general practice: how best to use cimetidine?

Authors:  A G Wade; D Rowley-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.